| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 2.96 MB | Adobe PDF |
Orientador(es)
Resumo(s)
ASAS and EULAR recommend the use of an improvement ≥1.1 in ASDAS at 12 weeks to determine the continuation of a bDMARD. However, it is debated whether improvements can occur and whether patients’ characteristics influence (time to) response.
Descrição
Fourteenth International Congress on Spondyloarthritides
Palavras-chave
Contexto Educativo
Citação
Editora
BMJ Publishing Group Ltd and European League Against Rheumatism
